ARTICLE SUMMARY:
Intrinsic Therapeutics, backed by stellar VCs, is hitting all the right marks as it gears up to launch its innovative implant for large anulus fissures based on superior data. But in this day-and-age of rising barriers to entry, that’s no guarantee of success.
Spine innovation is cyclical, and the past decade or so has been tough on entrepreneurs in the sector.
